{"product_id":"life-science-equipment-market-by-technology-spectroscopy-microscopy-chromatography-hplc-gc-tlc-pcr-immunoassay-sequencing-flow-cytometry-lab-automation-microarray-electrophoresis-incubator-centrifuge-end-user-global-forecast-to-2030","title":"Life Science Equipment Market by Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User - Global Forecast to 2030","description":"\u003cp\u003eLife Science Equipment Market By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Lab Automation, Microarray, Electrophoresis, Incubator, Centrifuge) End User– Global Forecast to 2030\u003cbr\u003e\nThe life science equipment market is expected to reach $92.21 billion by 2030, at a CAGR of 6.2% from 2023 to 2030.\u003c\/p\u003e\n\n\u003cp\u003eAfter extensive primary and secondary research, the report provides an in-depth analysis of the life science equipment market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the life science equipment market. The growth of the life science equipment market is driven by the increasing pharmaceutical and biotech R\u0026amp;D expenditures, government initiatives supporting life sciences R\u0026amp;D, the increasing prevalence of chronic and infectious diseases, and growth in initiatives to control environmental pollution. However, the high costs of advanced equipment and funding and infrastructure limitations in developing countries restrain the growth of this market.\u003c\/p\u003e\n\n\u003cp\u003eFurthermore, the growth in genomics and proteomics, the increasing awareness and growing adoption of personalized medicines, increasing automation and digitalization in the life sciences industry, and the increasing focus on food safety and quality are generating growth opportunities for the players operating in this market. However, the lack of skilled professionals required for operating advanced laboratory equipment and data security concerns are major challenges for market stakeholders.\u003c\/p\u003e\n\n\u003cp\u003eAmong the technologies included in the report, in 2023, the sequencing segment is projected to register the highest CAGR during the forecast period. The capability of sequencing technology to generate high-yield error-free throughput, the growing integration of this technology in clinical and research settings, and increasing partnerships and collaborations among sequencing instrument manufacturers to expand and improve product offerings are some of the factors contributing to the growth of the segment.\u003c\/p\u003e\n\n\u003cp\u003eAmong the end users included in the report, in 2023, the pharmaceutical and biotechnology industry segment is estimated to account for the largest share of the life science equipment market. The large market segment share is majorly attributed to the increased attention towards personalized medicine, growth in the number of research studies covering biologics and biosimilars, and growing collaborations among pharmaceutical \u0026amp; biotechnology companies and CROs.\u003c\/p\u003e\n\n\u003cp\u003eAn in-depth analysis of the geographical scenario of the life science equipment market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East \u0026amp; Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the life science equipment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East \u0026amp; Africa. The high prevalence of chronic and infectious diseases leading to a large number of approvals of biosimilars and generics, high adoption of advanced technologies, a well-established healthcare system, and increased funding activities for life science research are some of the factors supporting the largest share of this market.\u003c\/p\u003e\n\n\u003cp\u003eThe key players operating in the life science equipment market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and Qiagen N.V. (Netherlands).\u003c\/p\u003e\n\n\u003cp\u003eScope of the Report:\u003c\/p\u003e\n\n\u003cp\u003eLife Science Equipment Market Assessment—by Technology\u003c\/p\u003e\n\n\u003cp\u003eSpectroscopy\u003cbr\u003e\nMolecular Spectroscopy\u003cbr\u003e\nUV\/Vis Spectroscopy\u003cbr\u003e\nNuclear Magnetic Resonance (NMR)\u003cbr\u003e\nNear-Infrared (NIR) Spectroscopy\u003cbr\u003e\nInfrared (IR) Spectroscopy\u003cbr\u003e\nRaman Spectroscopy\u003cbr\u003e\nPolarimeters and Refractometers\u003cbr\u003e\nFluorescence \u0026amp; Luminescence Spectroscopy\u003cbr\u003e\nOther Molecular Spectroscopy Technologies\u003c\/p\u003e\n\n\u003cp\u003eNote:Other molecular spectroscopy technologies segment includes Raman spectroscopy, ellipsometry, and color measurement.\u003c\/p\u003e\n\n\u003cp\u003eMass Spectrometry\u003cbr\u003e\nQuadrupole LC\/MS\u003cbr\u003e\nTime of Flight LC\/MS (Q-TOF \u0026amp; LC-TOF)\u003cbr\u003e\nGas Chromatography-Mass Spectrometry (GC\/MS)\u003cbr\u003e\nFourier Transform Mass Spectrometry (FT\/MS)\u003cbr\u003e\nMatrix-Assisted Laser Desorption\/Ionization-Time of Flight Mass Spectroscopy (MALDI-TOF MS)\u003cbr\u003e\nPortable and In-Field Mass Spectroscopy\u003cbr\u003e\nTandem Mass Spectroscopy (MS\/MS)\u003cbr\u003e\nIon Trap Mass Spectroscopy (LC\/MS)\u003cbr\u003e\nAtomic Spectroscopy\u003cbr\u003e\nAtomic Absorbance Spectroscopy (AAS)\u003cbr\u003e\nX-Ray Fluorescence (XRF) Spectroscopy\u003cbr\u003e\nX-Ray Diffraction (XRD) Spectroscopy\u003cbr\u003e\nOther Atomic Spectroscopy Technologies\u003c\/p\u003e\n\n\u003cp\u003eNote:Other atomic spectroscopy technologies segment includes inductively coupled plasma (ICP) spectroscopy, glow discharge spectroscopy, and arc\/spark optical emission spectroscopy.\u003c\/p\u003e\n\n\u003cp\u003eSpectroscopy Software\u003cbr\u003e\nMicroscopy\u003cbr\u003e\nElectron Microscopy\u003cbr\u003e\nOptical Microscopy\u003cbr\u003e\nScanning Probe Microscopy\u003cbr\u003e\nOther Microscopy\u003cbr\u003e\nMicroscopy Software\u003cbr\u003e\nChromatography\u003cbr\u003e\nHigh-Performance Liquid Chromatography (HPLC)\u003cbr\u003e\nGas Chromatography (GC)\u003cbr\u003e\nLow Pressure Liquid Chromatography (LPLC)\u003cbr\u003e\nFlash Chromatography\u003cbr\u003e\nThin Layer Chromatography (TLC)\u003cbr\u003e\nIon Chromatography\u003cbr\u003e\nSupercritical Fluid Chromatography (SFC)\u003cbr\u003e\nChromatography Software\u003cbr\u003e\nLab Automation\u003cbr\u003e\nAutomated Workstations\u003cbr\u003e\nRobotic Systems\u003cbr\u003e\nAutomated Storage and Retrieval Systems (ASRS)\u003cbr\u003e\nLab Automation Software\u003cbr\u003e\nImmunoassay Analyzers\u003cbr\u003e\nChemiluminescence Immunoassay\u003cbr\u003e\nFluorescence Immunoassay\u003cbr\u003e\nRadioimmunoassay (RIA)\u003cbr\u003e\nColorimetric Immunoassay\u003cbr\u003e\nOther Immunoassay Analyzers\u003cbr\u003e\nImmunoassay Software\u003cbr\u003e\nPCR\u003cbr\u003e\nRT-PCR\u003cbr\u003e\nConventional PCR\u003cbr\u003e\nDigital PCR\u003cbr\u003e\nPCR Software\u003cbr\u003e\nSequencing\u003cbr\u003e\nFlow Cytometry\u003cbr\u003e\nCell-Based Flow Cytometers\u003cbr\u003e\nBead-Based Flow Cytometers\u003cbr\u003e\nFlow Cytometry Software\u003cbr\u003e\nIncubators\u003cbr\u003e\nMicroarray\u003cbr\u003e\nDNA Microarrays\u003cbr\u003e\nProtein Microarray\u003cbr\u003e\nTissue Array\u003cbr\u003e\nOther Microarrays\u003cbr\u003e\nMicroarray Software\u003c\/p\u003e\n\n\u003cp\u003eNote:Other microarrays segment includes glycan microarray, carbohydrate microarray, and chemical compounds microarray.\u003c\/p\u003e\n\n\u003cp\u003eCentrifuges\u003c\/p\u003e\n\n\u003cp\u003eCentrifuges, by Type\u003c\/p\u003e\n\n\u003cp\u003eDevices\u003cbr\u003e\nMultipurpose Centrifuges\u003cbr\u003e\nMicrocentrifuges\u003cbr\u003e\nMini-centrifuges\u003cbr\u003e\nUltracentrifuges\u003cbr\u003e\nOther Centrifuges\u003cbr\u003e\nCentrifuge Accessories\u003c\/p\u003e\n\n\u003cp\u003eCentrifuges, by Model\u003c\/p\u003e\n\n\u003cp\u003eBenchtop Centrifuges\u003cbr\u003e\nFloor-standing Centrifuges\u003c\/p\u003e\n\n\u003cp\u003eCentrifuges, by Application\u003c\/p\u003e\n\n\u003cp\u003eResearch Applications\u003cbr\u003e\nGenomics\u003cbr\u003e\nMicrobiology\u003cbr\u003e\nCellomics\u003cbr\u003e\nProteomics\u003cbr\u003e\nClinical Applications\u003cbr\u003e\nDiagnostics\u003cbr\u003e\nBlood Processing and Screening\u003cbr\u003e\nOther Applications\u003cbr\u003e\nElectrophoresis\u003cbr\u003e\nGel Electrophoresis\u003cbr\u003e\nCapillary Electrophoresis\u003cbr\u003e\nGel Documentation Systems and Software\u003cbr\u003e\nOther Equipment\u003c\/p\u003e\n\n\u003cp\u003eNote:Other equipment segment includes autoclaves, stirrers \u0026amp; shakers, mixers, baths, hot plates, ovens \u0026amp; furnaces, and balances.\u003c\/p\u003e\n\n\u003cp\u003eLife Science Equipment Market Assessment - by End User\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical and Biotechnology Industry\u003cbr\u003e\nAcademic \u0026amp; Research Institutes\u003cbr\u003e\nHospitals and Diagnostic Laboratories\u003cbr\u003e\nAnalytical Testing Laboratories\u003cbr\u003e\nAgriculture and Food Industry\u003cbr\u003e\nForensic Laboratories\u003cbr\u003e\nOther End Users\u003c\/p\u003e\n\n\u003cp\u003eNote:Other end users include blood banks and industries, such as cosmetics, chemicals, oil \u0026amp; gas, electronics \u0026amp; semiconductors, automotive, aerospace, ceramics, plastics, rubber, and paints \u0026amp; coatings.\u003c\/p\u003e\n\n\u003cp\u003eLife Science Equipment Market Assessment - by Geography\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nU.K.\u003cbr\u003e\nFrance\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nSwitzerland\u003cbr\u003e\nRest of Europe (RoE)\u003cbr\u003e\nAsia-Pacific (APAC)\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRest of APAC (RoAPAC)\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRest of LATAM (RoLATAM)\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nUAE\u003cbr\u003e\nRest of Middle East \u0026amp; Africa (RoMEA)\u003c\/p\u003e\n\n\u003cp\u003eLife Science Equipment Market - Global Opportunity Analysis and Industry Forecast (2023–2030) - Report SummaryReport MetricsDetailsYears Considered2021 - 2030Base Year2022Forecast Period2023-2030Page Count686Units ReferencedValue (USD Million)Segments\/Key TopicsMarket by Technology and End UserRegions CoveredNorth America, Europe, Asia-Pacific, Latin America, Middle East \u0026amp; AfricaKey Companies MentionedAgilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V. (Netherlands)\u003c\/p\u003e\n\n\u003cp\u003eFAQs About the Report\u003c\/p\u003e\n\n\u003cp\u003eWhat is the focus of the life science equipment study?\u003c\/p\u003e\n\n\u003cp\u003eThis study offers a detailed assessment of the life science equipment market, including the market sizes \u0026amp; forecasts for market segments such as technology and end user. The study also provides an in-depth analysis of various segments \u0026amp; subsegments of the life science equipment at the regional and country levels.\u003c\/p\u003e\n\n\u003cp\u003eWhat is the revenue generated from the sale of life science equipment across the globe? At what rate is their demand expected to grow for the next 5–7 years?\u003c\/p\u003e\n\n\u003cp\u003eThe life science equipment market is projected to reach $92.21 billion by 2030, at a CAGR of 6.2% during the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eBased on technology, which segment is expected to account for the largest share of the market in 2023?\u003c\/p\u003e\n\n\u003cp\u003eIn 2023, the spectroscopy segment is expected to account for the largest share. The wide range of applications, high precision and sensitivity, advancements in technology, and large user base contribute to the large market share of this segment.\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, which segment is slated to grow fastest over the forecast period?\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, the hospitals and diagnostic laboratories segment is expected to grow with the highest CAGR due to growth in the number of hospitals and diagnostic laboratories and initiatives to increase diagnostic capabilities of the hospitals due to the emergence of sudden pandemic situations.\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the life science equipment market?\u003c\/p\u003e\n\n\u003cp\u003eThe growth of this market is attributed to several factors, including increasing funding and investment in the pharma, biotech, and life science industries, government initiatives to strengthen R\u0026amp;D for biotech and life sciences, rising prevalence of chronic diseases, and growing clinical capabilities globally. Additionally, the growth in genomics and proteomics, increasing awareness, growing adoption of personalized medicine, and emerging economies are expected to provide significant opportunities for players operating in the market.\u003c\/p\u003e\n\n\u003cp\u003eWho are the major players operating in the life science equipment market?\u003c\/p\u003e\n\n\u003cp\u003eThe key players profiled in the life science equipment study are Agilent Technologies, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Waters Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V. (Germany).\u003c\/p\u003e\n\n\u003cp\u003eWhich regions\/countries are expected to dominate the life science equipment market in 2023?\u003c\/p\u003e\n\n\u003cp\u003eIn 2023, North America is expected to dominate the life science equipment market. North America’s major market share is attributed to the presence of key market players, the well-established life science industry, and substantial spending on R\u0026amp;D activities by pharmaceutical and biotech companies.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 686 Pages \/ MCW16232962","offer_id":47648499401010,"sku":null,"price":5850.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/life-science-equipment-market-by-technology-spectroscopy-microscopy-chromatography-hplc-gc-tlc-pcr-immunoassay-sequencing-flow-cytometry-lab-automation-microarray-electrophoresis-incubator-centrifuge-end-user-global-forecast-to-2030","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}